As of April 18, 2025, Biophytis S.A. (ALBPS.PA) has a market cap of $4.248 million USD. According to our data, Biophytis S.A. is ranked No.9045 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $4.25 M |
-38.06%
|
Dec 31, 2024 | $6.86 M |
-81.38%
|
Dec 29, 2023 | $36.83 M |
1,008.70%
|
Dec 30, 2022 | $3.32 M |
-90.71%
|
Dec 31, 2021 | $35.74 M |
-46.26%
|
Dec 31, 2020 | $66.51 M |
362.81%
|
Dec 31, 2019 | $14.37 M |
-88.29%
|
Dec 31, 2018 | $0.12 B |
-63.75%
|
Dec 29, 2017 | $0.34 B |
21.50%
|
Dec 30, 2016 | $0.28 B |
-65.93%
|
Dec 30, 2015 | $0.82 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$3.74 B |
-0.000 M
|
![]() USA
|
![]() uniQure
QURE
|
$0.70 B |
-0.000 M
|
![]() Netherlands
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.70 B |
0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.67 B |
-0.000 M
|
![]() USA
|
![]() Abeona Therapeutics
ABEO
|
$0.24 B |
-0.000 M
|
![]() USA
|
Market Cap | = | ALBPS.PA Stock Price | * | ALBPS.PA Shares Outstanding |
= | $0.21 | * | 20.15 M | |
= | $4.25 M |